AR031674A1 - Composicion farmaceutica que comprende un sensibilizador de insulina en combinacion con otro compuesto farmaceuticamente activo y uso de dicho sensibilizador en combinacion con otro compuesto farmaceuticamente activo para fabricarla - Google Patents
Composicion farmaceutica que comprende un sensibilizador de insulina en combinacion con otro compuesto farmaceuticamente activo y uso de dicho sensibilizador en combinacion con otro compuesto farmaceuticamente activo para fabricarlaInfo
- Publication number
- AR031674A1 AR031674A1 ARP000104514A ARP000104514A AR031674A1 AR 031674 A1 AR031674 A1 AR 031674A1 AR P000104514 A ARP000104514 A AR P000104514A AR P000104514 A ARP000104514 A AR P000104514A AR 031674 A1 AR031674 A1 AR 031674A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- salt
- pharmaceutical composition
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25044399 | 1999-09-03 | ||
| JP2000056021 | 2000-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR031674A1 true AR031674A1 (es) | 2003-10-01 |
Family
ID=26539777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000104514A AR031674A1 (es) | 1999-09-03 | 2000-08-30 | Composicion farmaceutica que comprende un sensibilizador de insulina en combinacion con otro compuesto farmaceuticamente activo y uso de dicho sensibilizador en combinacion con otro compuesto farmaceuticamente activo para fabricarla |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1212090A2 (pl) |
| KR (1) | KR20020063555A (pl) |
| CN (1) | CN1372476A (pl) |
| AR (1) | AR031674A1 (pl) |
| AU (1) | AU6868000A (pl) |
| CA (1) | CA2383946A1 (pl) |
| CO (1) | CO5180632A1 (pl) |
| HK (1) | HK1044711A1 (pl) |
| HU (1) | HUP0203285A3 (pl) |
| NO (1) | NO20021036L (pl) |
| PE (1) | PE20010580A1 (pl) |
| PL (1) | PL354295A1 (pl) |
| RU (1) | RU2002108346A (pl) |
| WO (1) | WO2001017513A2 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1695716A2 (en) * | 2000-12-26 | 2006-08-30 | Sankyo Company, Limited | Medicinal compositions containing diuretics and insulin sensitizers |
| WO2002080936A1 (en) | 2001-04-04 | 2002-10-17 | Ortho Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| JP4590158B2 (ja) | 2001-04-04 | 2010-12-01 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | グルコース再吸収阻害剤およびレチノイド−ｘ受容体モジュレーターを含んで成る併用療法 |
| FR2838968A1 (fr) * | 2002-04-30 | 2003-10-31 | Lipha | Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete |
| EP1514869A1 (en) * | 2002-06-12 | 2005-03-16 | Sumitomo Pharmaceuticals Company, Limited | Indole, indazole, and benzazole derivative |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04501722A (ja) * | 1988-11-14 | 1992-03-26 | ジ・アップジョン・カンパニー | 抗―糖尿病、抗―肥満症および抗―アテローム性動脈硬化症薬として有用なα―アミノ―インドール―３―酢酸 |
| DE69100282T3 (de) * | 1990-02-09 | 2001-01-11 | Pharmacia & Upjohn Co., Kalamazoo | Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie. |
| CN1070477C (zh) * | 1994-11-29 | 2001-09-05 | 大日本制药株式会社 | 吲哚衍生物 |
-
2000
- 2000-08-29 PE PE2000000887A patent/PE20010580A1/es not_active Application Discontinuation
- 2000-08-30 AR ARP000104514A patent/AR031674A1/es not_active Application Discontinuation
- 2000-09-01 KR KR1020027002851A patent/KR20020063555A/ko not_active Application Discontinuation
- 2000-09-01 CN CN00812420A patent/CN1372476A/zh active Pending
- 2000-09-01 HU HU0203285A patent/HUP0203285A3/hu unknown
- 2000-09-01 WO PCT/JP2000/005951 patent/WO2001017513A2/en not_active Application Discontinuation
- 2000-09-01 CA CA002383946A patent/CA2383946A1/en not_active Abandoned
- 2000-09-01 PL PL00354295A patent/PL354295A1/pl not_active Application Discontinuation
- 2000-09-01 RU RU2002108346/14A patent/RU2002108346A/ru not_active Application Discontinuation
- 2000-09-01 CO CO00065981A patent/CO5180632A1/es not_active Application Discontinuation
- 2000-09-01 AU AU68680/00A patent/AU6868000A/en not_active Abandoned
- 2000-09-01 EP EP00956872A patent/EP1212090A2/en not_active Withdrawn
-
2002
- 2002-03-01 NO NO20021036A patent/NO20021036L/no not_active Application Discontinuation
- 2002-08-15 HK HK02105969.4A patent/HK1044711A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20021036L (no) | 2002-04-26 |
| WO2001017513A3 (en) | 2001-09-20 |
| PL354295A1 (pl) | 2004-01-12 |
| KR20020063555A (ko) | 2002-08-03 |
| CA2383946A1 (en) | 2001-03-15 |
| AU6868000A (en) | 2001-04-10 |
| HUP0203285A2 (hu) | 2003-01-28 |
| RU2002108346A (ru) | 2003-11-20 |
| HUP0203285A3 (en) | 2003-02-28 |
| WO2001017513A2 (en) | 2001-03-15 |
| NO20021036D0 (no) | 2002-03-01 |
| HK1044711A1 (zh) | 2002-11-01 |
| CO5180632A1 (es) | 2002-07-30 |
| CN1372476A (zh) | 2002-10-02 |
| PE20010580A1 (es) | 2001-05-25 |
| EP1212090A2 (en) | 2002-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2935035T3 (es) | Compuestos de benzofuranilo y benzoxazolilo sustituídos y usos farmacéuticos de los mismos | |
| ES2572803T3 (es) | Estimuladores de GCs | |
| AU2016372028B2 (en) | Methods of treating hyperalgesia | |
| AR118805A2 (es) | Terapia de combinación para el tratamiento de la diabetes | |
| NO20074012L (no) | 1-tio-D-glucitolderivater | |
| DE602007009420D1 (de) | Oxadiazolderivate als s1p1-rezeptor-agonisten | |
| PE20081487A1 (es) | DERIVADOS DE NICOTINAMIDA COMO INHIBIDORES DE 11ßHSD1 | |
| PE20081228A1 (es) | Compuesto heteromonociclico | |
| PE20070833A1 (es) | Compuestos de pirimidinil benzotiofeno | |
| EA200602260A1 (ru) | Применение замещенных хинолиновых производных для лечения заболеваний, вызываемых микобактериями, резистентными к лекарственным средствам | |
| BRPI0506765A (pt) | composto ou um seu sal, hidrato e/ou pró-droga farmaceuticamente aceitáveis, composição farmacêutica, métodos para inibir a produção de beta-amilóide em um paciente e para tratar de uma doença, kit farmacêutico, uso de um composto ou de uma composição | |
| GEP20094727B (en) | Oxyindole derivatives as 5ht4 receptor agonists | |
| NO20075723L (no) | Tiazolforbindelser og fremgangsmater for anvendelse | |
| AR029469A1 (es) | Compuesto de azaindol, compuesto de azaindol de utilidad como intermediario para preparar el anterior, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima | |
| JP2010506942A5 (pl) | ||
| BRPI0707718A2 (pt) | uso de um composto | |
| AR069772A1 (es) | Derivados heterociclicos, una composicion farmaceutica y un juego que los comprenden y su uso en la preparacion de un medicamento para el tratamiento de una infeccion parasitaria. | |
| RU2010119487A (ru) | Пиримидилиндолиновое соединение | |
| JP2007527904A5 (pl) | ||
| NO20051901L (no) | Nye antimycobakterielle sammensetninger og pyrrole derivater som antimycobakterielle sammensetninger | |
| Testai et al. | Cardiac ATP-sensitive potassium channels: a potential target for an anti-ischaemic pharmacological strategy | |
| JP2015178458A (ja) | ベンゼン環縮合含窒素５員複素環式化合物、またはその薬理学的に許容される塩 | |
| NO20051900L (no) | Kinazolinderivater som SRC tyrosin kinase inhibitorer | |
| WO2015157376A1 (en) | Asparagine endopeptidase (aep) inhibitors for managing cancer and compositions related thereto | |
| IE60707B1 (en) | Pharmacologically active substituted benzamides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |